THIS RESEARCH GROUP WAS ESTABLISHED WITH THE AIM OF, THROUGH THE COLLABORATION OF CLINICAL AND BASIC RESEARCHERS, DEEPENING THE KNOWLEDGE OF THE PHYSIOLOGY, GENETICS AND CLINICS OF LOW-PREVALENCE DISEASES.
The Research Group on Molecular, Cellular and Genomic Biomedicine (BMCG) was accredited in 2010 and it is composed of a total of 21 researchers, ten of them belonging to the joint Unit for Rare Diseases CIPF_IIS La Fe. It is led by Dr. José M. Millán. The group is multidisciplinary and is made up of ophthalmologists, ENT doctors, geneticists, molecular biologists and biochemists, and participates as a member in the CIBER of Rare Diseases. Its objective is to deepen the knowledge of the physiology, genetics and clinics of diseases that fundamentally affect the organs of vision and hearing but also neuromuscular and neurodegenerative organs, seeking the immediate application of the results of this research to the clinical practice for the benefit of the patient.
PRESENTATION
GET TO KNOW US BETTER
RESEARCH STAFF
THE PEOPLE WHO MAKE IT ALL POSSIBLE
José María Millán Salvador
PUBLICATIONS
OUR SCIENTIFIC CONTRIBUTIONS
NUTRARET: Effect of 2-Year Nutraceutical Supplementation on Redox Status and Visual Function of Patients With Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Trial
Frontiers in Nutrition 2022 Mar, DOI: 10.3389/fnut.2022.847910, Vol. 9, pag. 847910-847910
Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration.
Antioxidants 2020 Apr, DOI: 10.3390/antiox9040313, Vol. 9, pag.
